Cleveland Clinic Cancer Advances

Rahul Tendulkar, MD, radiation oncologist at Cleveland Clinic Cancer Center, joins the Cancer Advances podcast to talk about the PSMA PET scan for patients with prostate cancer. Listen as Dr. Tendulkar explains the benefits and how the scan is changing the way we think about and treat prostate cancer.

Petar Bajic, MD, a urologist in the Center for Men's Health at Cleveland Clinic's Glickman Urological and Kidney Institute, joins the Cancer Advances podcast to discuss Prostate Cancer Survivorship. Listen as Dr. Bajic discusses the difficulties patients face following prostate cancer treatment and the options available to help with urinary and sexual-health issues. He also discusses the...

J. Joseph Melenhorst, PhD, Director of the Cell Therapy and Immuno-Engineering program and Vice Chair of the Center for Immunotherapy and Precision Immuno-Oncology, joins the Cancer Advances podcast to talk about the future of CAR T-Cell Therapy. Listen as Dr. Melenhorst discusses the progress being made, barriers to overcome, and and how we can improve cellular therapy to treat even more types of...

Nicole Peters, Executive Director of VeloSano in the Cleveland Clinic Philanthropy Institute, joins the Cancer Advances podcast to talk about VeloSano, a year-round fundraising initiative that supports lifesaving cancer research at Cleveland Clinic. Listen as Nicole discusses how VeloSano was started, our flagship Bike to Cure weekend, and highlights of how 100% of the funds go toward advancing ca...

Cleveland Clinic hematology oncologist, Allison Winter, MD, joins the Cancer Advances podcast to discuss the early alert process for aggressive lymphoma. Listen as Dr. Winter covers the importance of time to treat for this disease and what Cleveland Clinic is doing to help see patients sooner.

Director of the Lung Cancer Medical Oncology Program at Cleveland Clinic Taussig Cancer Institute, Nathan A. Pennell, MD, PhD joins the Cancer Advances podcast to discuss the KRYSTAL-1 trial, a new treatment option for patients with advanced non-small-cell lung cancer with KRASG12C mutation. Listen as Dr. Pennell explains the trial and findings that were presented at the American Society of Clinic...

Julie Nowicki PT, DPT, a physical therapist at Cleveland Clinic's Children’s, joins the 100th episode of the Cancer Advances podcast to talk about the Pediatric Hematology/Oncology Mobility Program. Listen as Julie discusses the program and the benefit of physical therapy for children undergoing cancer treatments.

Michael Fritz, MD, Section Head of Facial Plastic and Microvascular Surgery in Cleveland Clinic's Head & Neck Institute, joins the Cancer Advances podcast to discuss anterolateral thigh fascia lata rescue flap for osteoradionecrosis. Listen as Dr. Fritz highlights how the operation allows patients to get back to their everyday lives sooner.

Harry (Adrian) Lesmana, MD, pediatric hematologist/oncologist and medical geneticist at Cleveland Clinic Children's joins the Cancer Advances podcast to talk about pediatric cancer predispositions. Listen as Dr. Lesmana describes gene predispositions for solid tumors vs hematologic cancers as well as the study he is working on to increase the ability to identify these genes through genomic se...

Yogen Saunthararajah, MD, hematologist/oncologist at Cleveland Clinic Cancer Center, joins the Cancer Advances podcast to discuss his study on repairing cancer cells. Listen as Dr. Saunthararajah discusses how he is trying to change the mindset from search and destroy to replenishment and repair.

Rachel Georgopoulos, MD, pediatric otolaryngologist and Director of the Thyroid Head and Neck Oncology and Pediatric Endocrine (Thyroid HOPE) Center, and Stefanie Thomas, MD, hematologist/oncologist at Cleveland Clinic Children’s join the Cancer Advances podcast to discuss the rise in pediatric thyroid cancer cases. Listen as they discuss the possible factors causing the increase in cases and the...

Neurologist/Neuro-oncologist in Cleveland Clinic’s Rose Ella Burkhardt Brain Tumor & Neuro-Oncology Center, Glen Stevens, DO, PhD, joins the Cancer Advances podcast to talk about the treatment of recurrent glioblastoma. Listen as Dr. Stevens discusses how a study mixing old principles with a new technique may disrupt the BBB, allowing chemotherapy to reach tumor cells.

Byron Lee, MD, PhD, a urologist in Cleveland Clinic's Glickman Urological and Kidney Institute joins the Cancer Advances podcast to discuss expanding surgical options for patients with bladder cancer. Listen as Dr. Lee compares robotic surgery verses open surgery and what we are doing to improve patient outcomes.

Vice Chair of the Department of Hematology and Medical Oncology, and head and neck medical oncologist, Jessica Geiger, MD joins the Cancer Advances podcast to talk about formulating guidelines for salivary gland tumors. Listen as Dr. Geiger explains the six main clinical questions that the guidelines aims to answer.

Peter Rasmussen, MD, cerebral vascular surgeon and Chief Clinical Officer of Virtual Second Opinions by Cleveland Clinic, joins the Cancer Advances podcast to discuss the benefits of Virtual Second Opinions. Listen as Dr. Rasmussen talks about this service at Cleveland Clinic and our goal to give patients the best opinion on what they can do now and in the future.

Lucy Boyce Kennedy, MD, hematology and medical oncologist at Cleveland Clinic Cancer Center, joins the Cancer Advances podcast talk about improving outcomes for patients with metastatic melanoma. Listen as Dr. Kennedy explains how treatment for this disease has improved over the last 10+ years.

Faiz Anwer, MD, hematology oncologist at Cleveland Clinic Cancer Center, joins the Cancer Advances podcast to discuss CAR T-cell therapy for Multiple Myeloma. Listen as Dr. Anwer discusses the trials aiming to move CAR T-cell therapy treatment to the forefront.

Jason Valent, MD, Director of the Multiple Myeloma Program and Co-Director of the Amyloidosis Program at Cleveland Clinic Cancer Center, joins the Cancer Advances podcast to discuss the developments of the CAEL-101 trial for patients with AL amyloidosis. Listen as Dr. Valent talks about the discoveries and changes in treatment in each phase of the trial.

Arun Singh, MD, Director of Ophthalmic Oncology at Cleveland Clinic Cole Eye Institute, joins the Cancer Advances podcast to discuss uveal melanoma. Listen as Dr. Singh explains the symptoms to look out for, treatment, and new therapies in development for this rare eye cancer.

Urologic oncologist in the Glickman Urological and Kidney Institute, Zeyad Schwen, MD joins the Cancer Advances podcast to discuss transperineal biopsy and advances in screening for prostate cancer. Listen as Dr. Schwen explains the benefits of the transperineal prostate biopsy technique and why with the use of better imaging, as well as reduced risks of infection, this technique is coming to the...

Suneel Kamath, MD, hematologist/medical oncologist and Siva Raja, MD, PhD, Surgical Director of the Center for Esophageal Diseases joins the Cancer Advances podcast to discuss the Esophageal Cancer Program. Listen as Dr. Kamath and Dr. Raja discuss this multidisciplinary program and the significant advancements that have been made over the last several years including less invasive therapies to tr...

Aaron Gerds, MD, MS, hematologist in Cleveland Clinic Cancer Center’s Leukemia & Myeloid Disorders Program joins the Cancer Advances podcast to talk about acute myeloid leukemia. Listen as Dr. Gerds discusses less intensive therapies for acute myeloid leukemia and their impact on mortality.

Director of Head and Neck Research and surgical oncologist at Cleveland Clinic, Natalie Silver, MD, MS, joins the Cancer Advances podcast to talk about head and neck cancers and the treatment barriers we are trying to overcome. Listen as Dr. Silver explains how she is trying to bridge the gap between the clinical and translational research with her work on vaccines.

Betty Hamilton, MD, Interim Director of the Blood and Marrow Transplant (BMT) Program at Cleveland Clinic joins the Cancer Advances podcast to discuss research and findings that were presented at the 2021 American Society of Hematology Annual Meeting (ASH). Listen as Dr. Hamilton discusses graft-versus-host disease and the study that evaluates a new regimen.

Rabi Hanna, MD, Chair of the Department of Pediatric Hematology, Oncology and Blood and Marrow Transplantation at Cleveland Clinic Children's joins the Cancer Advances podcast to discuss the use of gene therapy in sickle cell disease. Listen as Dr. Hanna describes how the last several years have brought significant advancements in the field, expanding our understanding and treatment of sickle...